Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine
Aging biology is a promising and burgeoning research area that can yield dual-purpose pathways and protein targets that may impact multiple diseases, while retarding or possibly even reversing age-associated processes. One widely used approach to classify a multiplicity of mechanisms driving the agi...
Main Authors: | Aliper, A. (Author), de Magalhães, J.P (Author), Izumchenko, E. (Author), Leung, G.H.D (Author), Leung, H.W (Author), Liu, B.H.M (Author), Long, X. (Author), Moskalev, A. (Author), Ozerov, I.V (Author), Pun, F.W (Author), Ren, F. (Author), Wang, J. (Author), Zhavoronkov, A. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Connecting genetics and gene expression data for target prioritisation and drug repositioning
by: Enrico Ferrero, et al.
Published: (2018-05-01) -
Computational Drug Repositioning: Current Progress and Challenges
by: Younhee Ko
Published: (2020-07-01) -
Computational-based drug repurposing methods in COVID-19
by: Yosef Masoudi-Sobhanzadeh
Published: (2020-07-01) -
Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets
by: Suhas Vasaikar, et al.
Published: (2016-11-01) -
COVID-19 Drug Discovery Using Intensive Approaches
by: Ayumu Asai, et al.
Published: (2020-04-01)